Clinical Associate Professor Dr. Van Hellerslia Receives $231,000 Genentech Sponsorship to Reduce the Impact of Stroke on Vietnamese Americans

Van Hellerslia, PharmD, BCPS, a clinical associate professor at the Temple University School of Pharmacy, and two faculty colleagues have been awarded a $231,000 Independent Medical Education grant sponsored by Genentech. She and her team will use the funds for programs to prevent and mitigate the effects of stroke among Vietnamese Americans.

Dr. Hellerslia will work with Charles Ruchalski, PharmD, a clinical professor, and Tina Tran, PharmD, an assistant professor, on their proposed project, ‘Vietnamese American Community of Stroke Care: a Pharmacist driven Capacity Building Initiative: “Viet-Capacity.”’ The project aims “to equip and empower 25-30 Vietnamese speaking pharmacists to establish a community-based outreach program where they will deliver stroke education to at least 40 Vietnamese speaking patients.”  

Furthermore, within the first year, the team of pharmacists plans to deliver and measure the impact of delivering evidence-based stroke recognition, risk factor, and emergency response education to 1,000 Vietnamese-speaking patients. The team’s Vietnamese language and cultural competency will be key to the effectiveness of their program.

“I’m grateful for this opportunity to leverage the capacity of our pharmacists to close healthcare disparities among a vulnerable population and hope that this program will serve as a framework for future initiatives supporting immigrant health,” Dr. Hellerslia commented.

Dr. Hellerslia is also a clinical pharmacist in the Department of Neurology at Temple University of Hospital and an assistant professor in the Lewis Katz School of Medicine Department of Neurology.

Read about Dr. Hellerslia’s path from adversity to success in pharmacy as a child refugee of post-war Vietnam.